SUSAN NAVARRO: Open Payments
NPI 1629473251 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 45 payments from 7 companies in 2025. Trend: 2023 $922 · 2024 $770 · 2025 $825
Food & beverage: $825
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $473 |
| Janssen Biotech, Inc. | 3 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $101 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Intercept Pharmaceuticals, Inc. | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $16 |
Products named: RINVOQ, TREMFYA, SKYRIZI, ENTYVIO, XIFAXAN, LINZESS, VOQUEZNA, OCALIVA.
Industry payments across MA — which companies pay providers there.
